Barclays PLC Has $526,000 Position in Red Violet, Inc. (NASDAQ:RDVT)

Barclays PLC lifted its stake in Red Violet, Inc. (NASDAQ:RDVT) by 240.7% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 18,502 shares of the company’s stock after acquiring an additional 13,072 shares during the period. Barclays PLC’s holdings in Red Violet were worth $526,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the company. State Street Corp lifted its position in shares of Red Violet by 5.7% in the 3rd quarter. State Street Corp now owns 188,993 shares of the company’s stock worth $5,377,000 after acquiring an additional 10,199 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Red Violet by 16.0% in the second quarter. Dimensional Fund Advisors LP now owns 86,511 shares of the company’s stock valued at $2,196,000 after purchasing an additional 11,964 shares in the last quarter. Marshall Wace LLP raised its stake in shares of Red Violet by 323.4% in the second quarter. Marshall Wace LLP now owns 56,561 shares of the company’s stock valued at $1,437,000 after purchasing an additional 43,203 shares in the last quarter. Los Angeles Capital Management LLC lifted its position in Red Violet by 158.3% in the third quarter. Los Angeles Capital Management LLC now owns 56,050 shares of the company’s stock worth $1,595,000 after purchasing an additional 34,348 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in Red Violet by 11.6% during the second quarter. Bank of New York Mellon Corp now owns 40,960 shares of the company’s stock worth $1,040,000 after buying an additional 4,264 shares in the last quarter. 63.56% of the stock is owned by institutional investors and hedge funds.

Red Violet Price Performance

Shares of Red Violet stock opened at $35.01 on Friday. The company’s fifty day moving average price is $35.54 and its two-hundred day moving average price is $29.83. The firm has a market capitalization of $482.86 million, a PE ratio of 97.25 and a beta of 1.49. Red Violet, Inc. has a 52-week low of $16.56 and a 52-week high of $39.88.

Red Violet Announces Dividend

The firm also recently declared a dividend, which will be paid on Friday, February 14th. Investors of record on Friday, January 31st will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, January 31st.

Insiders Place Their Bets

In other Red Violet news, President James Patrick Reilly sold 10,000 shares of the stock in a transaction on Monday, November 25th. The stock was sold at an average price of $37.25, for a total transaction of $372,500.00. Following the completion of the transaction, the president now directly owns 272,124 shares in the company, valued at $10,136,619. This represents a 3.54 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Peter Benz sold 22,300 shares of Red Violet stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $37.43, for a total value of $834,689.00. Following the transaction, the director now directly owns 80,766 shares of the company’s stock, valued at approximately $3,023,071.38. The trade was a 21.64 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 9.50% of the company’s stock.

About Red Violet

Red Violet, Inc, a software and services company, specializes in proprietary technologies and applying analytical capabilities to deliver identity intelligence in the United States. It offers idiCORE, an investigative solution used to address various organizational challenges, which include due diligence, risk mitigation, identity authentication, fraud detection and prevention, customer acquisition, and regulatory compliance; and FOREWARN, an app-based solution that provides instant knowledge before face-to-face engagement with a consumer, as well as helps professionals to identify and mitigate risk.